This inventor holds 2 USPTO granted patents. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: Judith Siuciak: Innovator in Neurotrophin Research
Introduction
Judith Siuciak is a prominent inventor based in Tarrytown, NY (US). She has made significant contributions to the field of neurotrophin research, focusing on methods that utilize these proteins for therapeutic purposes. With a total of 2 patents, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Judith's latest patents include a method of producing analgesia using neurotrophins and a method of treating depression using neurotrophins. The first patent describes the use of infusions of brain-derived neurotrophic factor, neurotrophin-3, or neurotrophin-4 to produce analgesia in mammals. Additionally, these neurotrophins are proposed for treating other diseases or disorders mediated by serotonin. The second patent highlights the infusion of neurotrophins, particularly brain-derived neurotrophic factor, as effective agents for alleviating symptoms of depression. This is demonstrated by a reduction of 'despair' in the animal forced swim test, suggesting that alterations in serotonin levels caused by neurotrophins could be beneficial for other disorders linked to serotonin activity.
Career Highlights
Judith Siuciak is currently associated with Regeneron Pharmaceuticals, Inc., where she continues her innovative research. Her work has garnered attention for its potential applications in treating pain and mood disorders, showcasing her commitment to advancing medical science.
Collaborations
Some of Judith's notable coworkers include Charles A Altar and Ronald M Lindsay, who have collaborated with her on various research initiatives. Their combined expertise contributes to the advancement of neurotrophin research and its applications.
Conclusion
Judith Siuciak's contributions to neurotrophin research exemplify her dedication to innovation in the medical field. Her patents reflect a promising future for treatments targeting pain and depression, highlighting the importance of her work in advancing therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile